Outlook Therapeutics, Inc. — Cash Flow Charts
2 years of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-52M
Free Cash Flow
$-52M
Investing Cash Flow
—
Financing Cash Flow
$45M
Capex
—
Stock-Based Comp
$9M
Debt Issued
$33M
Debt Repaid
$36M
D&A
$117K
SBC Allocated Expense
$9M